← Leaderboards
Jane Jooyun Kim
Harvard School Of Public Health
$4,057,428
Attributed
$15,541,261
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2012–24$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$15,541,261 · 3
By mechanism
U01$14,336,508 · 2
R01$1,204,753 · 1
Top collaborators
- Karen Canfell17 shared
- Shalini L Kulasingam17 shared
- Ruanne Vanessa Barnabas16 shared
- Inge Mcm De Kok11 shared
- Marjolein Van Ballegooijen6 shared
- Jennifer S Haas1 shared
- Aruna Kamineni1 shared
- Jasmin Anita Tiro1 shared
Most similar at Harvard School Of Public Health
Same institution · by research overlap
- Karen Canfell$2,852,675
- Inge McM De Kok$1,573,200
- Michael David Hughes$621,748
Others in their field
Top investigators on “Malignant Neoplasm Of Cervix Uteri”
- David Heimbrook · Leidos Biomedical Research, Inc.$177,328,706
- Philip J Disaia · University Of California Irvine$75,863,106
- Walter John Curran · Thomas Jefferson University$47,862,860
- Larry Arthur$27,902,757
- Norman Wolmark · Nsabp Foundation, Inc.$21,221,311
- T.-C. Wu · Howard University$18,468,441
Research focus
Malignant Neoplasm Of Cervix UteriCervicalPoliciesCancer ControlComparativeCancer Health DisparityWomanGuidelinesHuman PapillomavirusBaseVaccinationCervical Cancer ScreeningUnited StatesScreeningSeriesPolicy MakerPrevention StrategyTechnologyCollaborationsCancer Intervention And Surveillance Modeling NetworkMalignant NeoplasmsCost EffectivenessComparative EffectivenessCost
Grant awards (21)
Comparative Modeling to Inform Cervical Cancer Control Policies$1,171,441
U01 · FY2024 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,225,767
U01 · FY2023 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$375,112
U01 · FY2023 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,243,668
U01 · FY2022 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies: USPSTF Supplement$382,146
U01 · FY2022 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies: METRICS PROSPR Supplement Phase 2$312,500
U01 · FY2022 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$42,462
U01 · FY2022 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,290,361
U01 · FY2021 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies - Moonshot Supplement$449,781
U01 · FY2021 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$75,750
U01 · FY2021 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,370,142
U01 · FY2020 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,183,281
U01 · FY2019 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$262,250
U01 · FY2019 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,222,591
U01 · FY2018 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,225,410
U01 · FY2017 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,291,168
U01 · FY2016 · CA · contact PI
Comparative Modeling to Inform Cervical Cancer Control Policies$1,212,678
U01 · FY2015 · CA · contact PI
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases$308,121
R01 · FY2015 · CA · contact PI
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases$298,877
R01 · FY2014 · CA · contact PI
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases$289,634
R01 · FY2013 · CA · contact PI
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases$308,121
R01 · FY2012 · CA · contact PI